Nuvo Research Inc (NRIFF) 5.5499 $NRIFF Nuvo's Revamped

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nuvo Research Inc (NRIFF) 5.5499 $NRIFF

Nuvo's Revamped Strategy Should Unlock Significant Value
Jason Napodano, CFA - at Seeking Alpha - Wed May 27, 8:41AM CDT

HZNP: 19.27 (+0.72)

Nuvo Research: Buy The Cash And Get The Company For Free
JMY Investments - at Seeking Alpha - Tue May 05, 10:32AM CDT


Is There Any Potential Left In Horizon Pharma Stock?
Max Grigoryev - at Seeking Alpha - Fri Mar 20, 1:55PM CDT

JNJ: 98.24 (+1.09), ACT: 298.98 (-2.94), PFE: 34.41 (+0.33), AZN: 32.35 (+0.11), HZNP: 19.27 (+0.72), MYL: 43.55 (+0.82), TEVA: 60.88 (+0.77)

Nuvo Research Still Worth The Risk
Michael Colavecchia, CFA - Seeking Alpha - Fri Feb 27, 6:46AM CST
Nuvo Research (OTCPK: OTCPK:NRIFF , or NRI on the TSX) reported Q4 and full year results on February 19th, and the investment thesis from my February 10th article remains intact. Here are the key elements to the story, with updates, that each...

Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST

MNK: 68.13 (+1.23), FLXN: 15.10 (-0.38), XENE: 9.23 (-0.41), HZNP: 19.27 (+0.72), AMPE: 3.06 (+0.02), CBYL: 3.94 (-0.01), ANIK: 34.57 (+0.05)

Nuvo Research May Be Worth The Risk Now
Michael Colavecchia, CFA - Seeking Alpha - Tue Feb 10, 7:36AM CST
I have been following this story for some time, searching for the right entry point. And now is the time. For those of you who are not familiar with the story of Nuvo Research ( OTCPK:NRIFF ), here is a brief summary. The company has a commercial...

Flexion patient dosing underway in lead product study
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:27PM CST

MNK: 68.13 (+1.23), FLXN: 15.10 (-0.38), XENE: 9.23 (-0.41), HZNP: 19.27 (+0.72), AMPE: 3.06 (+0.02), CBYL: 3.94 (-0.01), ANIK: 34.57 (+0.05)

Carbylan Therapeutics on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 12:13PM CST

MNK: 68.13 (+1.23), FLXN: 15.10 (-0.38), XENE: 9.23 (-0.41), HZNP: 19.27 (+0.72), AMPE: 3.06 (+0.02), ANIK: 34.57 (+0.05), CBYL: 3.94 (-0.01)

Medical Marijuana Goes To Market: Daniel Pearlstein Of M Partners
Life Sciences Report - at Seeking Alpha - Thu Jan 08, 10:42AM CST
Life sciences analyst Daniel Pearlstein of Toronto-based M Partners brings knowledge of the biotech sector and hands-on experience in the startup realm to understanding value and growth in small- and micro-cap life sciences companies. In this...
MNK: 68.13 (+1.23), AUPH: 2.99 (+0.06), HZNP: 19.27 (+0.72), GSK: 41.96 (+0.42), BMY: 64.49 (+0.87)

Update: Horizon Pharma Acquires U.S. Rights For Pennsaid 2%, Long Case Strengthens
ONeil Trader - at Seeking Alpha - Sat Oct 18, 4:30PM CDT

HZNP: 19.27 (+0.72)

Horizon acquires U.S. rights to osteoarthritis drug
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 9:17AM CDT

HZNP: 19.27 (+0.72)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 9

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 136

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 112

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 347

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 118

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 53

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

What $1000 Invested in Nutanix 5 Years Ago Looks Like Now

Updated Category News Views 136

The Growth Journey of Nutanix Stock Nutanix (NASDAQ: NTNX) has shown impressive growth over the last five years, outpacing the market with an annualized return of 15.61%. With a current market capitalization exceeding $15.57 billion, the company has established itself as a significant player in the industry. Your Investment Potential If you were an investor who purchased...

Continue Reading
WANF Transitions to Independence, Strengthening Local News in Atlanta

Updated Category News Views 517

WANF Evolves into an Independent Television Station Gray Media's local television station WANF is embarking on an exciting new journey. Transitioning from more than three decades as a CBS affiliate, WANF will become an independent station, enabling it to better serve the Atlanta community. This strategic shift represents a significant opportunity to enhance the quality of...

Continue Reading
Monarch Quantum Poised for NASA’s Quantum Gravity Gradiometer

Updated Category News Views 228

Game Changer for Quantum Technology If you thought the quantum sector was crawling, buckle up. Monarch Quantum, Inc. just landed a huge gig—delivering its integrated Quantum Light Engines™ for NASA’s upcoming Quantum Gravity Gradiometer Pathfinder mission. That’s not just a feather in their cap; it’s a serious validation of their tech chops. This isn’t just...

Continue Reading
GLD and Mitchell & Ness: A Dynamic Retail Collaboration

Updated Category News Views 18

An Unlikely Fusion of Jewelry and Jerseys Here's a heads-up for you: two unlikely heavyweights, GLD from the world of jewelry and Mitchell & Ness from the land of sports nostalgia, have teamed up. Kicking things off back in May with the launch of Mitchell & Ness' new flagship in Philadelphia, they've designed a retail playground where style knows no bounds. Business in...

Continue Reading
NovoEd Hits Big: 14 Awards from Brandon Hall 2026

Updated Category News Views 17

Big Wins at the Brandon Hall HCM Awards You don't win 14 medals at a prestigious event like the Brandon Hall Group's HCM Excellence Awards without turning some heads. NovoEd, alongside industry giants 3M, Abbott, and Kohler, did just that in 2026. Talk about an impressive lineup. NovoEd's talent development tech is evidently hitting all the right notes across the board....

Continue Reading